However, studies have shown that IgMN is a distinct clinicopathological diagnosis comprising patients with predominant mesangial IgM deposits and who do not meet established criteria for MCD and FSGS. The gene discussed is CD40LG; the disease is focal segmental glomerulosclerosis.